PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2008Journal of Leukocyte Biology187 citationsOpen Access

Is serum amyloid A an endogenous TLR4 agonist?

View Full Paper
SSSilvana SandriDRDúnia RodriguezEGE. A. Gomes

Key Points

Key points are not available for this paper at this time.

Abstract

Serum amyloid A (SAA), a classical acute-phase protein, is produced predominantly by hepatocytes in response to injury, infection, and inflammation. It has been shown that SAA primes leukocytes and induces the expression and release of proinflammatory cytokines. Here, we report that SAA induces NO production by murine peritoneal macrophages. Using specific inhibitors, we showed that NO production was dependent on inducible NO synthase thorough the activation of ERK1/2 and p38 MAPKs. Moreover, SAA activity was decreased after proteolysis but not with polymyxin B, a lipid A antagonist. Finally, we found that NO production was dependent on functional TLR4, a receptor complex associated with innate immunity. Macrophages from C3H/HeJ and C57BL/10ScCr mice lacking a functional TLR4 did not respond to SAA stimulation. In conclusion, our study makes a novel observation that SAA might be an endogenous agonist for the TLR4 complex on macrophages. The contribution of this finding in amplifying innate immunity during the inflammatory process is discussed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sandri et al. (2008) studied this question.

synapsesocial.com/papers/6a278b6a2152eedf3561aca9https://doi.org/10.1189/jlb.0407203
Ask AI
Helpful
Bookmark
Share
View Full Paper